Insider Transactions in Q2 2021 at Centessa Pharmaceuticals PLC (CNTA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2021
|
Gregory M Weinhoff Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$200,000
$20.0 P/Share
|
|
Jun 02
2021
|
Marella Thorell Chief Accounting Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$20,000
$20.0 P/Share
|
|
Jun 02
2021
|
Arjun Goyal Director |
BUY
Open market or private purchase
|
Indirect |
750,000
+16.02%
|
$15,000,000
$20.0 P/Share
|
|
Jun 02
2021
|
Arjun Goyal Director |
BUY
Conversion of derivative security
|
Indirect |
3,181,818
+50.0%
|
-
|
|
Jun 02
2021
|
Iqbal J Hussain General Counsel |
BUY
Open market or private purchase
|
Indirect |
5,500
+50.0%
|
$110,000
$20.0 P/Share
|
|
Jun 02
2021
|
Iqbal J Hussain General Counsel |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$60,000
$20.0 P/Share
|
|
Jun 02
2021
|
Thomas Templeman Chief Technology Officer |
BUY
Open market or private purchase
|
Direct |
250
+50.0%
|
$5,000
$20.0 P/Share
|
|
Jun 02
2021
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Open market or private purchase
|
Indirect |
3,000
+50.0%
|
$60,000
$20.0 P/Share
|
|
Jun 02
2021
|
David M Chao Chief Administrative Officer |
BUY
Open market or private purchase
|
Direct |
500
+50.0%
|
$10,000
$20.0 P/Share
|
|
Jun 02
2021
|
Medicxi Ventures Management (Jersey) LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
600,000
+13.54%
|
$12,000,000
$20.0 P/Share
|
|
Jun 02
2021
|
Medicxi Ventures Management (Jersey) LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,931,818
+37.42%
|
-
|
|
Jun 02
2021
|
Francesco De Rubertis Director |
BUY
Open market or private purchase
|
Indirect |
600,000
+13.54%
|
$12,000,000
$20.0 P/Share
|
|
Jun 02
2021
|
Francesco De Rubertis Director |
BUY
Conversion of derivative security
|
Indirect |
1,931,818
+37.42%
|
-
|
|
Jun 02
2021
|
Gap (Bermuda) L.P. Director |
BUY
Open market or private purchase
|
Direct |
1,500,000
+13.41%
|
$30,000,000
$20.0 P/Share
|
|
May 27
2021
|
Antoine Yver EVP & Chairman of Development |
BUY
Grant, award, or other acquisition
|
Direct |
833,897
+50.0%
|
-
|